NICE joins forces with Canadian peer to offer scientific advice to the pharma industry
pharmafile | February 6, 2019 | News story | Research and Development, Sales and Marketing | CADTH, Canada, NICE, UK, pharma
NICE has announced a collaboration with its Canadian counterpart, the Canadian Agency for Drugs and Technology in Health (CADTH), with the goal of offering the pharma industry parallel scientific advice so that they may better develop robust health technology assessment (HTA) applications.
Specifically, the two agencies will seek to educate companies on how to offer value-based clinical and economic evidence to support the regulatory submissions of their products, offering feedback on such submissions alongside expert advice from clinicians, health economists and patient representatives.
This feedback and advice will take the form of separate advice reports from both organisations as well as a joint summary which will help firms evaluate the effectiveness of their submissions and prepare for future HTAs.
“We recognise the inherent difficulties faced by developers in designing clinical trial programmes that meet the precise requirements of multiple international markets,” explained Jeanette Kusel, Director of NICE Scientific Advice. “This new collaboration with CADTH uses the synergies between the English and Canadian systems and provides companies with comprehensive and practical advice from both countries through a single, streamlined process.”
Michelle Mujoomdar, Acting Vice President, Evidence Standards at CADTH, added: “This exciting new international collaboration between two established HTA bodies will help pharmaceutical companies develop relevant evidence for CADTH and NICE while streamlining the process of obtaining advice in two distinct markets.”
Matt Fellows
Related Content
Combination treatments: Takeda’s Implementation Framework and the broader landscape
Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment …
LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …
Addenbrooke’s hospital offers first self-service digital eye test
Addenbrooke’s Hospital, Cambridge, has become the first in the UK to deploy a digital self-testing …
